跳至主要内容
临床试验/NCT07048431
NCT07048431尚未招募不适用

Evaluation of Chemotherapy-Induced Neuropathic Pain Using Shear Wave Elastography Measurements of the Tibial Nerve

Ankara Etlik City Hospital1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年9月15日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
Shear Wave Elastography (SWE) Stiffness Value

研究概览

简要总结

This observational study aims to evaluate the tibial nerve stiffness using Shear Wave Elastography (SWE) in patients with chemotherapy-induced peripheral neuropathy (CIPN) compared to healthy volunteers. A total of 25 patients with a DN4 score ≥4 and 25 healthy controls will be assessed. Parameters including nerve diameter, cross-sectional area, depth, and shear wave velocity (V value) will be measured. Demographic and clinical data such as age, gender, chemotherapy protocol, duration, comorbidities, and medications will also be collected. The goal is to investigate SWE as a non-invasive diagnostic tool for CIPN by identifying differences in nerve elasticity between groups.

详细描述

Chemotherapy-induced peripheral neuropathy (CIPN) is a common dose-limiting side effect observed in 30-40% of patients receiving neurotoxic chemotherapy. CIPN typically presents with sensory symptoms such as paresthesia, numbness, balance disturbances, heightened pain sensitivity, and deep tendon reflex loss. The severity and progression of neuropathy vary widely among patients.

The diagnosis of peripheral neuropathy is based on clinical symptoms and is often supported by nerve conduction studies such as electromyography (EMG). However, EMG can be time-consuming and may be insufficient in advanced cases due to loss of nerve action potentials. Furthermore, subclinical cases of neuropathy may go undetected by EMG.

Recent evidence suggests that pathophysiological changes in CIPN may lead to increased nerve stiffness. Shear Wave Elastography (SWE), a non-invasive ultrasound-based technique, allows for quantitative evaluation of tissue elasticity by measuring shear wave velocity (V value in m/s) and calculating stiffness (E value in kPa). Unlike strain elastography, SWE does not require manual compression, making it more objective and reproducible.

This observational, case-control study aims to assess tibial nerve elasticity using SWE in patients diagnosed with CIPN and to compare the findings with healthy controls. A total of 25 patients with CIPN (defined as a DN4 score ≥4) and 25 age-matched healthy volunteers without neuropathy symptoms will be included. All participants will undergo ultrasound and SWE measurements of bilateral tibial nerve.

Parameters recorded will include the anteroposterior and lateral-medial diameter, cross-sectional area, distance from the skin, and the mean shear wave velocity (V value) obtained from three repeated measurements. In addition, demographic and clinical data such as age, gender, chemotherapy protocol and duration, comorbidities, and current medications will be collected.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Age between 18 and 75 years
  • •DN4 score ≥4
  • •Anatomical suitability for tibial nerve ultrasound and SWE assessment
  • •Providing written informed consent

排除标准

  • •Presence of diabetes mellitus
  • •Alcohol use
  • •Polyneuropathy due to genetic or toxic causes
  • •Fracture, skin lesion, or edema in the lower extremity
  • •Severe systemic diseases (e.g., liver, kidney, heart, or lung)
  • •Inability to visualize the tibial nerve anatomically
  • •Cognitive or psychiatric disorders preventing cooperation

结局指标

主要结局

Shear Wave Elastography (SWE) Stiffness Value

时间窗: Single SWE measurement performed within the first week of study inclusion

Shear Wave Elastography (SWE) is an imaging technique used to quantify tissue stiffness by measuring the propagation speed (V, m/s) of shear waves and converting it into elasticity values (E, kilopascals, kPa). Higher values may indicate fibrosis or increased tension, while lower values may reflect fatty infiltration or atrophy. In peripheral nerves, SWE has been used to assess elasticity in neuropathic conditions. Research shows that affected nerves in neuropathy exhibit increased stiffness compared to healthy nerves. Both shear wave velocity (V) and elasticity modulus (E) can be measured, offering objective, quantitative data to detect and monitor structural nerve changes.

次要结局

未报告次要终点

研究者

发起方
Ankara Etlik City Hospital
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Ufuk Turan, MD

Principal Investigator

Ankara Etlik City Hospital

研究点 (1)

Loading locations...

相似试验

招募中
不适用
Chemotherapy Induced Neuropathy in Cancer PatientsChemotherapy-induced Peripheral Neuropathy
NCT06491082Swami Rama Himalayan University124
Unknown
不适用
Electrical Stimulation and Chemotherapy Induced Peripheral NeuropathyChemotherapy Induced Peripheral Neuropathy (CIPN)
NCT02088996Uppsala University70
进行中(未招募)
不适用
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With CancerAnatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Prognostic Stage IA Breast Cancer AJCC v8Prognostic Stage IB Breast Cancer AJCC v8Prognostic Stage IIA Breast Cancer AJCC v8Prognostic Stage III Breast Cancer AJCC v8Stage IB Ovarian Cancer AJCC v8Stage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Stage IIIA Ovarian Cancer AJCC v8Stage IIIC Ovarian Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8Prognostic Stage I Breast Cancer AJCC v8Stage IA Ovarian Cancer AJCC v8Stage IC Ovarian Cancer AJCC v8Stage IIB Lung Cancer AJCC v8Stage IIIA1 Ovarian Cancer AJCC v8Stage IIIB Ovarian Cancer AJCC v8Lung Non-Small Cell CarcinomaPrognostic Stage IIIA Breast Cancer AJCC v8Stage I Lung Cancer AJCC v8Stage IB Lung Cancer AJCC v8Prognostic Stage IIB Breast Cancer AJCC v8Prognostic Stage IIIB Breast Cancer AJCC v8Prognostic Stage IIIC Breast Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8Stage IA2 Lung Cancer AJCC v8Stage IA3 Lung Cancer AJCC v8Stage IIA Ovarian Cancer AJCC v8Stage IIB Ovarian Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Prognostic Stage II Breast Cancer AJCC v8Stage I Ovarian Cancer AJCC v8Stage II Lung Cancer AJCC v8Stage II Ovarian Cancer AJCC v8Stage IIA Lung Cancer AJCC v8Stage III Ovarian Cancer AJCC v8Stage IIIA2 Ovarian Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8
NCT03939481SWOG Cancer Research Network1,336
已完成
不适用
EvaLuation of ChemoTherapy induced peRIpheral neuropathy by Current perception thresholdCancer
JPRN-UMIN000012003Medical oncology, Mie University Hospital80
撤回
不适用
Chemotherapy-Induced Peripheral Neuropathy SurveyChemotherapy-induced Peripheral NeuropathyMyelomaBreast CancerColorectal Cancer
NCT01016028M.D. Anderson Cancer Center